How long should initiation of calcineurin inhibitors be delayed to protect renal function in liver transplantation?

Transplantation Proceedings

Volumn 43, Issue 3, 2011, Pages 697-698

  Rafael Valdivia, L ^a   Mendoza, M A ^a   Martinez Saldivar, B ^a   Sanchez Fueyo, A ^a   Brunet, M ^a   Garcia Valdecasas, J C ^a   Rimola, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; CALCINEURIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MEDICAL AUDIT; MIDDLE AGED; TACROLIMUS;

EID: 79954519044     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.091     Document Type: Conference Paper

References (6)

1. J.M. Neuberger, R.D. Mamelok, and P. Neuhaus Delayed introduction of reduced-dose tacrolimus and renal function in liver transplantation: The ReSpECT study Am J Transplant 9 2009 327
2. E.M. Yoshida, P.J. Marotta, and P.D. Greig Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil and delayed, low dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial Liver Transpl 11 2005 1064
3. T. Soliman, H. Hetz, and C. Burghuber Short term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation Liver Transpl 13 2007 1039
4. I. Bajjoka, L. Hsaiky, and K. Brown Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors Liver Transpl 14 2008 66
5. T.A. Gonwa, M.L. Mai, and L.B. Melton End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy Transplantation 72 2001 1934
6. A.C. Ferreira, F. Nolasco, and D. Carvalho Impact of RIFLE classification in liver transplantation Clin Transplant 24 2010 394